(Q38335170)

English

Differentiated prostatic antigen expression in LNCaP cells following treatment with bispecific antisense oligonucleotides directed against BCL-2 and EGFR.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Differentiated prostatic antigen expression in LNCaP cells following treatment with bispecific antisense oligonucleotides directed against BCL-2 and EGFR. (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

author name string

Marvin Rubenstein

1

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Courtney M P Hollowell

2

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Patrick Guinan

3

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

publication date

15 May 2011

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Medical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

835-841

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Role of RNase H in hybrid-arrested translation by antisense oligonucleotides

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9977-X

21 January 2018

Bispecific antisense oligonucleotides with multiple binding sites for the treatment of prostate tumors and their applicability to combination therapy

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9977-X

21 January 2018

Combination chemotherapy employing bispecific antisense oligonucleotides having binding sites directed against an autocrine regulated growth pathway and bcl-2 for the treatment of prostate tumors

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9977-X

21 January 2018

Multigene targeting of signal transduction pathways for the treatment of breast and prostate tumors: comparison between combination therapies employing bispecific oligonucleotides with either Rapamycin or Paclitaxel

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9977-X

21 January 2018

Construction of a bispecific antisense oligonucleotide containing multiple binding sites for the treatment of hormone insensitive prostate tumors

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9977-X

21 January 2018

Bispecific antisense oligonucleotides having binding sites directed against an autocrine regulated growth pathway and bcl-2 for the treatment of prostate tumors

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9977-X

21 January 2018

Treatment of MCF-7 breast cancer cells employing mono- and bispecific antisense oligonucleotides having binding specificity toward proteins associated with autocrine regulated growth and BCL-2.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9977-X

21 January 2018

Does the prostate retain an endogenous antiviral defense system suggesting a past viral etiology for cancer?

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9977-X

21 January 2018

Targeting of biotinylated oligonucleotides to prostate tumors with antibody-based delivery vehicles

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9977-X

21 January 2018

Synthesis of branched antisense oligonucleotides having multiple specificities. Treatment of hormone insensitive prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9977-X

21 January 2018

FORMATION OF A THREE-STRANDED POLYNUCLEOTIDE MOLECULE

1 reference

https://api.crossref.org/works/10.1007%2FS12032-011-9977-X

21 January 2018

Interferon-gamma enhances expression of cellular receptors for tumor necrosis factor

1 reference

https://pubmed.ncbi.nlm.nih.gov/21573974

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antisense oligonucleotide intralesional therapy for human PC-3 prostate tumors carried in athymic nude mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/21573974

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bispecific antisense oligonucleotides have activity comparable to monospecifics in inhibiting expression of BCL-2 in LNCaP cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21573974

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant Gamma Interferon Induces HLA-DR Expression on Cultured Human Keratinocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/21573974

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12032-011-9977-X

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38335170&oldid=2201578122"